Maddalena Opioid Switching Score in patients with cancer pain
- PMID: 35500284
- DOI: 10.1097/j.pain.0000000000002669
Maddalena Opioid Switching Score in patients with cancer pain
Abstract
Evaluation of opioid switching (OS) for cancer pain has not been properly assessed. The aim of this study was to assess an integrated score (Maddalena Opioid Switching Score) as a simple and repeatable tool to evaluate the outcomes of OS, facilitating the interpretation and comparison of studies, and information exchange among researchers. The integrated score took into account pain intensity, intensity of opioid-related symptoms, and cognitive function by using an author's formula. Physical and psychological symptoms were evaluated by the Edmonton Symptom Assessment Scale and Patient Global Impression (PGI) by the minimal clinically important difference. One hundred six patients were analyzed. Ninety-five patients were switched successfully, and 11 patients underwent a further OS and/or an alternative procedure. The Maddalena Opioid Switching Score significantly decreased after OS and was highly correlated to PGI of improvement ( P < 0.0005). In patients with unsuccessful OS, no significant changes in the Maddalena Opioid Switching Score and PGI were observed. A significant reduction in Edmonton Symptom Assessment Scale items intensity was observed after OS. The Maddalena Opioid Switching Score resulted to be a sensitive instrument for measuring the clinical improvement produced by OS.
Copyright © 2022 International Association for the Study of Pain.
References
-
- Bedart G, Zeng L, Zhang L, Lauzon N, Holden L, Tsao M, Danjoux C, Barnes E, Sahgal A, Poon M, Chow E. Minimal clinically important differences in the Edmonton Symptom Assessment System in patients with advanced cancer. J Pain Symptom Manage 2013;46:192–200.
-
- Bouassirha D, Attal N, Alchaar H, Boureau F, Brochet B, Btuxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H, Lanteri-Minet M, Laurent B, Mick G, Serrie A, Valade D, Vicaut E. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). PAIN 2005;114:29–36.
-
- Breibart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The Memorial Delrium Assessment Scale. J Pain Symptom Manage 1997;13:128–37.
-
- de la Cruz M, Yennu S, Liu D, Wu J, Reddy A, Bruera E. Increased symptom expression among patients with delirium admitted to an acute palliative care unit. J Palliat Med 2017;20:638–41.
-
- Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003;25:406–11.